SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-260265
Filing Date
2012-06-05
Accepted
2012-06-05 16:43:02
Documents
5
Period of Report
2012-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d359900d8k.htm 8-K 35021
2 REGISTRATION RIGHTS AGREEMENT d359900dex101.htm EX-10.1 60454
3 ARTICLES OF AMENDMENT d359900dex102.htm EX-10.2 61375
4 PRESS RELEASE d359900dex991.htm EX-99.1 12526
5 GRAPHIC g359900image002.jpg GRAPHIC 3307
  Complete submission text file 0001193125-12-260265.txt   175550
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 12889642
SIC: 2834 Pharmaceutical Preparations